secwatch / observer
8-K filed August 20, 2025, 7:59 PM ET CIK 0000316253
M&A confidence high sentiment neutral materiality 0.90

ENZO BIOCHEM INC: M&A transaction — Enzo Biochem completes merger with Bethpage Parent; stockholders to receive $0.70/share

ENZO BIOCHEM INC

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ENZO BIOCHEM INC: Bylaws amended and restated in connection with merger.

Change
bylaw amendment
Exact text from the filing
the bylaws of the Company, as in effect immediately prior to the Merger, were amended and restated, in accordance with the Merger Agreement and the NYBCL, to be in the form of the bylaws attached as Exhibit 3.2 hereto
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ENZO BIOCHEM INC: Certificate of incorporation amended and restated in connection with merger.

Change
charter amendment
Exact text from the filing
the certificate of incorporation of the Company, as in effect immediately prior to the Merger, was amended and restated, in accordance with the Merger Agreement and the New York Business Corporation Law (the “NYBCL”), to be in the form of the certificate of incorporation attached as Exhibit 3.1 hereto
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

ENZO BIOCHEM INC underwent a change of control involving Bethpage Parent, Inc. (closed 2025-08-20).

Action
change of control
Counterparty
Bethpage Parent, Inc.
Closing
2025-08-20
Exact text from the filing
On August 20, 2025 (the “Closing Date”), pursuant to the Merger Agreement, Merger Sub merged with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent.
View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR
accession 0001213900-25-078736
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.